ライフサイエンスコーパス: premedication

1 in the prescribing practices of steroids for premedication.

2 lerance instead of the indiscriminate use of premedication.

3 ion rate was low (5% EBd) and mitigated with premedication.

4 oses of ipilimumab safely, the majority with premedication.

5 receive additional doses of ipilimumab with premedication.

6 reactions were reported despite the lack of premedication.

7 was attributable, in part, to corticosteroid premedication.

8 significantly higher (p = .03) with atropine premedication.

9 urs and use of antiemetics and antigastritis premedication.

10 All patients received standard premedication.

11 Frequent HSR may warrant prophylactic premedication.

12 All infusions were well tolerated without premedication.

13 re, minimum alveolar concentration, sex, and premedication.

14 tributed solely to the use of corticosteroid premedications.

15 inations [19%]; different ICM and no steroid premedication: 10 of 322 examinations [3%]; odds ratio [

16 they received steroid premedication (steroid premedication: 44 of 172 patients [26%] vs no premedicat

17 2 [95% CI, 70-73]; n = 330) compared with no premedication (73 [95% CI, 71-74]; n = 319) or placebo (

18 remedication: 44 of 172 patients [26%] vs no premedication: 73 of 298 patients [25%]; OR, 1.00 [95% C

19 ation and the same ICM (same ICM and steroid premedication: 80 of 423 examinations [19%]; different I

20 he frequency of reactions despite the use of premedication (a "breakthrough reaction"), and the frequ

21 Premedications alleviated some of the infusion-related r

22 Premedication almost always includes dexamethasone, whic

23 We measured serum creatinine and GFR after premedication and after the CT examination.

24 l risks of recurrent reactions with those of premedication and product avoidance when making these re

25 occurred with ABI-007 despite the absence of premedication and shorter administration time.

26 eedingly low risk of severe reaction, use of premedication and test doses are unnecessary, and that o

27 ion analyzed improve in patients who receive premedication and the minimum dose of contrast material.

28 the observed rate when using corticosteroid premedication and the same GBCA (36%; 95% CI: 26%, 48%;

29 tions than did patients who received steroid premedication and the same ICM (same ICM and steroid pre

30 t allergic-like reactions than using steroid premedication and the same ICM that caused the previous

31 s who underwent contrast-enhanced CT without premedication and who had similar rates of 13 comorbid d

32 sciplinary preoperative assessment, adequate premedications, and close intra- and postoperative monit

33 The choice of premedication, anesthetic, analgesic and antiemetic drug

34 armacological interventions such as sedative premedication are used to treat this clinical phenomenon

35 Graded vaccine dosing, skin testing, and premedication as risk-stratification strategies did not

36 avior Checklist [CBCL]) were administered at premedication baseline and at the end of the MPH trial w

37 ts (GBCAs) that occur despite corticosteroid premedication (breakthrough reactions) are not well unde

38 We examined twenty times enhanced CT without premedication, but no subjects had side effect such as a

39 estigated whether intravenous hydrocortisone premedication can reduce ATI.

40 determine whether routine TAVR-CTA, without premedication, could safely defer and guide the need for

41 patients incurred complications relating to premedication, CTA, or FFR protocol.

42 A single low dose of oral midazolam premedication did not alter the global perioperative pat

43 n with lorazepam compared with placebo or no premedication did not improve the self-reported patient

44 we could find a correlation between steroid premedication dosing and the incidence or severity of HS

45 avenously over 1 hour without corticosteroid premedications every 3 weeks with weekly hematologic mon

46 , 0.33]; P < .001; different ICM and steroid premedication: five of 166 patients [3%]; OR, 0.12 [95%

47 tified according to trial center, the use of premedication for intubation (yes or no), and postmenstr

48 as the preparation, planning, and potential premedication for patients with previous reactions.

49 romide reaction) with 12- and 2-hour steroid premedication for preventing repeat acute allergic-like

50 as a single 10 mg dose of dexamethasone, as premedication for taxanes to prevent HSRs is preferable

51 Recommended measures include premedication, frequent assessing for symptoms and sever

52 roup (68 [95% CI, 65-72]; n = 87) and the no premedication group (73 [95% CI, 69-77]; n = 57) or the

53 2 minutes (95% CI, 11-13 minutes) for the no premedication group, and 13 minutes (95% CI, 12-14 minut

54 ved a different ICM with and without steroid premedication had a significantly lower rate of repeat r

55 ticoids, although intravenous glucocorticoid premedication improved tolerability during the first rit

56 Premedication in children is best achieved with oral mid

57 antihistamines and/or glucocorticoid routine premedication in patients receiving low- or iso-osmolar

58 it with routine use of lorazepam as sedative premedication in patients undergoing general anesthesia.

59 This study reviews the pattern of steroid premedication in patients who received paclitaxel or doc

60 role for antihistamine and/or glucocorticoid premedication in specific chemotherapy protocols and rus

61 Premedication included analgesics, antihistamines, and 5

62 Background It is unclear whether steroid premedication is an effective means of preventing repeat

63 Sedative premedication is widely administered before surgery, but

64 rd paclitaxel 175 mg/m(2) intravenously with premedication (n = 225).

65 er ABI-007 260 mg/m(2) intravenously without premedication (n = 229) or standard paclitaxel 175 mg/m(

66 Despite omission of premedications, no significant hypersensitivity reaction

67 OKT3 induction for 7-14 days, but different premedication on days 0, 1, and 2.

68 The effect of oral midazolam premedication on patient satisfaction in older patients

69 utes without corticosteroid or antihistamine premedications on days 1, 8, and 15 of a 28-day cycle.

70 ents (8%) who were subsequently treated with premedications; one patient had grade 3 hypersensitivity

71 on formulation, and in patients who received premedication or with history of infusion-related reacti

72 cocorticoids, intravenous methylprednisolone premedication, or intravenous methylprednisolone premedi

73 ants each to receive 2.5 mg of lorazepam, no premedication, or placebo.

74 th use of the same agent with corticosteroid premedication (P = .10).

75 edication, or intravenous methylprednisolone premedication plus oral prednisone for 2 weeks.

76 nt infusions were administered with atropine premedication, preventing recurrence.

77 Intravenous glucocorticoid premedication reduced the frequency and intensity of fir

78 who received an oral 13-hour corticosteroid premedication regimen before contrast material-enhanced

79 ccelerated 5-hour intravenous corticosteroid premedication regimen before low-osmolality contrast-enh

80 A premedication regimen of KM produced superior sedation w

81 Patients received an abbreviated premedication regimen that consisted of ranitidine 50 mg

82 The initial premedication regimen was chosen by random assignment.

83 n rate noninferior to that of a 13-hour oral premedication regimen.

84 utic index and elimination of corticosteroid premedication required for solvent-based taxanes make th

85 inistration of high paclitaxel doses without premedication, resulting in significant antitumor activi

86 ne (Dex), an alpha-2 agonist widely used for premedication, sedation, anxiolysis and analgesia.

87 Intravenous hydrocortisone premedication significantly reduces ATI levels but does

88 oses and with antihistamine and beta-agonist premedication, stem cell factor therapy has been well to

89 regardless of whether they received steroid premedication (steroid premedication: 44 of 172 patients

90 on to outline the differences among sedative premedications such as midazolam, clonidine, and dexmede

91 technique involves administering a sedative premedication, such as midazolam.

92 After premedication, the dose of RATG was administered over 4

93 Regardless of carbidopa premedication, the xenografts were characterized by an e

94 bation, the use of atropine and lidocaine as premedications, the choice of sedative agents depending

95 ere was a significant difference between the premedication TMH, TMA, and TMD and after one and three

96 s a 1-hour IV infusion every 3 weeks without premedication to prevent hypersensitivity reactions (HSR

97 c) is complicated by neuropathy and requires premedication to prevent hypersensitivity-type reactions

98 Radiology Contrast Manual, which recommends premedication to prevent repeat hypersensitivity reactio

99 rituximab in chemotherapeutic regimens or as premedication to reduce infusion-related symptoms.

100 administering sevoflurane or desflurane with premedication using antiemetics.

101 e of adverse events among those who received premedication was 23-fold higher compared with those who

102 ydramine hydrochloride and/or corticosteroid premedication was added after hypersensitivity-like reac

103 icantly higher reaction rate particularly if premedication was administered (68% [95% CI, 64%-72%] vs

104 No corticosteroid premedication was administered and no hypersensitivity r

105 material, the patient's age and sex, whether premedication was given, the contrast agent used, the vo

106 The indirect cost and risk of HAI with premedication were estimated by using published data.

107 five administrations) without corticosteroid premedication, which did not differ (P = .82 and P = .17

108 Six weeks after streptozotocin premedication, Wistar male rats presenting blood sugar l

109 Premedication with 0.05 mg/kg of acepromazine was given,

110 Premedication with 4% lidocaine gel significantly reduce

111 mammography were randomly divided to receive premedication with acetaminophen, ibuprofen, and/or 4% l

112 Patient premedication with carbidopa seems to improve the accura

113 Premedication with clopidogrel has reduced thrombotic co

114 Premedication with corticosteroids and antihistamines wa

115 Conclusion Accelerated intravenous premedication with corticosteroids beginning 5 hours bef

116 astoma leptomeningeal dissemination, whereas premedication with corticosteroids prevents both inflamm

117 m-tolerated dose of IT mafosfamide following premedication with dexamethasone and morphine was 14 mg.

118 Premedication with dexamethasone, cimetidine, and diphen

119 Each child received intravenous premedication with either meperidine 2 mg/kg and midazol

120 The results suggest that premedication with intravenous morphine prior to CT chol

121 d 62 women; mean age, 37 years); 43 received premedication with intravenous morphine sulfate (0.04 mg

122 e surgery under general anesthesia, sedative premedication with lorazepam compared with placebo or no

123 Premedication with lorazepam did not improve the EVAN-G

124 re imaged with a 64-section CT scanner after premedication with oral atenolol and/or intravenous meto

125 th intravenous contrast administration after premedication with oral hydration and N-acetylcysteine.

126 Premedication with the antiemetic Kytril (granisetron hy

127 ty are effective lambdaU similar to sedative premedications, with the exception of parent present ind